Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.00
Ask:
2.20
Spread: 0.20 (10.00%)
Market Cap: £44.34m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Disposal

13 Oct 2011 07:00

RNS Number : 0875Q
Quintain Estates & Development PLC
13 October 2011
 



 

13 October 2011

Quintain Estates & Development plc

("Quintain" / "Company" / "Group")

 

Quintain Realises £34m from Student Accommodation Asset

 

Quintain announces the disposal of its recently completed student accommodation scheme, Dashwood Studios, to a discretionary single client account of Rockspring Property Investment Managers.

 

The sale price of £34m compares with the 31 March 2011 site valuation of £14.7m and subsequent construction expenditure of £17.8m.

 

Dashwood Studios is located in Elephant & Castle and attracts residents from several London universities in the surrounding area. It contains 232 high quality studio rooms, multiple communal living spaces and retail units on the ground floor. The entire scheme is let for the current academic year and the retail units are under offer.

 

This disposal demonstrates Quintain's ability to generate returns by applying its expertise to opportunities in specific alternative sectors. Quintain purchased the scheme in February 2011 and has worked closely with the developer over the summer to achieve completion in time for the start of the current academic year.

 

Rebecca Worthington, Finance Director of Quintain, said:

"Our in-depth knowledge of the student accommodation sector enabled us to identify Dashwood as a valuable opportunity, work with the developer to achieve completion over the summer, drive 100% occupancy prior to the start of the academic year and then dispose of the asset at a profit.

 

"Given the current challenges in the debt markets, our priority as a Group is to continue to strengthen our financial position. As part of this strategy, we are extending the maturity of our existing facilities and continue to reduce the level of corporate debt through a measured programme of disposals. The proceeds from the sale of Dashwood Studios will be used to reduce our forecast gearing levels."

 

 

For further information, please contact:

Quintain Estates & Development plc FTI Consulting

Rebecca Worthington / Cressida Curtis Dido Laurimore / Laurence Jones

Tel: +44 (0) 20 7495 8968 Tel: +44 (0) 20 7831 3113

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISLLFERIILFLIL
Date   Source Headline
1st Aug 20247:00 amRNSValkor Project Update
10th Jul 20247:00 amRNSMarine Project Update
26th Jun 20247:00 amRNSExtended agreement with BTG Bioliquids for bioMSAR
29th May 20247:00 amRNSRepresentation Agreement Addendum & Warrants Grant
28th May 20247:00 amRNSOCP Commercial Framework Agreement
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company
15th Oct 20154:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.